| Original language | English |
|---|---|
| Pages (from-to) | 15-15 |
| Number of pages | 1 |
| Journal | International Journal of Stroke |
| Volume | 12 |
| Publication status | Published - Aug 2017 |
Cite this
Hankey, G., & Hackett, M. (2017). Assessment of fluoxetine in stroke recovery (AFFINITY) trial: rationale, design and progress. International Journal of Stroke, 12, 15-15.
@article{b48c7cc7968b4405b93a101447d07c89,
title = "Assessment of fluoxetine in stroke recovery (AFFINITY) trial: rationale, design and progress",
author = "G. Hankey and M. Hackett",
year = "2017",
month = "8",
language = "English",
volume = "12",
pages = "15--15",
journal = "International Journal of Stroke",
issn = "1747-4930",
publisher = "Wiley Blackwell",
}
Hankey, G & Hackett, M 2017, 'Assessment of fluoxetine in stroke recovery (AFFINITY) trial: rationale, design and progress' International Journal of Stroke, vol. 12, pp. 15-15.
Assessment of fluoxetine in stroke recovery (AFFINITY) trial : rationale, design and progress. / Hankey, G.; Hackett, M.
In: International Journal of Stroke, Vol. 12, 08.2017, p. 15-15.Research output: Contribution to journal › Abstract/Meeting Abstract
TY - JOUR
T1 - Assessment of fluoxetine in stroke recovery (AFFINITY) trial
T2 - rationale, design and progress
AU - Hankey, G.
AU - Hackett, M.
PY - 2017/8
Y1 - 2017/8
M3 - Abstract/Meeting Abstract
VL - 12
SP - 15
EP - 15
JO - International Journal of Stroke
JF - International Journal of Stroke
SN - 1747-4930
ER -
Hankey G, Hackett M. Assessment of fluoxetine in stroke recovery (AFFINITY) trial: rationale, design and progress. International Journal of Stroke. 2017 Aug;12:15-15.